Because IL‐38 suppressed M1 macrophage accumulation and reduced MMP‐9 and MMP‐2 expression in the aortic wall (Figure 2), we examined the effects of IL‐38 treatment on the structures of the abdominal aortic wall in mouse angiotensin II infusion AAA model. The gene discussed is IL1F10; the disease is triple-A syndrome.